SNT 0.00% 3.5¢ syntara limited

Ann: Boehringer Initiating Phase 2a Study Diabetic Retinopathy, page-19

  1. 443 Posts.
    lightbulb Created with Sketch. 7
    $60m cash, circa $90m market cap, $500m plus potential for PXS-4278A alone, Loxl2 deal pending - trial to commence soon, takeover potential, lots of upside here over the next 6-12 months.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.000(0.00%)
Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.